{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:49:48Z","timestamp":1787683788671,"version":"build-2784847793"},"reference-count":0,"publisher":"AVES YAYINCILIK A.\u015e.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EJR"],"abstract":"<jats:p>Objective: Palindromic rheumatism (PR) is characterized by repetitive attacks of arthritis and\/or periarthritis. There is inadequate data regarding the role of low dose methotrexate in patients with PR. The aim of this study was to determine the efficacy of low dose methotrexate add-on therapy in patients withPR with inadequate response to hydroxychloroquine (HCQ) monotherapy.\n\nMethods: In this observational study, between August 2016 and July 2019, 15 patients with seropositive PR with inadequate response to HCQ (\u2265 2attacks per month even after 6 months of therapy) were included. All patients were treated with oral low dose methotrexate in addition to HCQ. The responses to therapy were monitored 3 and 6 months after adding methotrexate.\n\nResults: In our study, of the 15 patients with PR, two-third were female, with a mean age of 45.73\u00b19.18 years. All were seropositive (Rheumatoid factor positive in eight patients; anti-cyclic citrullinated peptide [CCP] positive in 11 patients; both Rheumatoid factor and anti-CCP positive in four patients). The average number of attacks at baseline was 5.6\u00b12.8, and the median duration of attacks was 2 years. All patients had significant response to add-on methotrexate therapy at follow-up after 3 and 6 months; none developed Rheumatoid arthritis (RA) after 2 years of follow-up.\n\nConclusion: Low dose methotrexate is an effective add-on therapy in patients with PR having inadequate response to HCQ.\n\nCite this article as: Padhan P, Thakur B. Effect of low dose methotrexate as an add-on therapy in patients with palindromic rheumatism unresponsive to hydroxychloroquine: An observational study. Eur J Rheumatol 2021; 8(3): 130-2.\n<\/jats:p>","DOI":"10.5152\/eurjrheum.2021.20062","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T08:16:29Z","timestamp":1622794589000},"page":"130-132","source":"Crossref","is-referenced-by-count":10,"title":["Effect of low dose methotrexate as an add-on therapy in patients with palindromic rheumatism unresponsive to hydroxychloroquine: An observational study"],"prefix":"10.5152","volume":"8","author":[{"given":"Prasanta","family":"Padhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3111","published-online":{"date-parts":[[2021,7,1]]},"container-title":["European Journal of Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/www.eurjrheumatol.org\/index.php\/pub\/article\/download\/478\/478","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T07:12:52Z","timestamp":1753773172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurjrheumatol.org\/index.php\/pub\/article\/view\/478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9,24]]}},"URL":"https:\/\/doi.org\/10.5152\/eurjrheum.2021.20062","relation":{},"ISSN":["2148-4279"],"issn-type":[{"value":"2148-4279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}